Alpha 2.0
Login Register
» Authors » Vishalakshi Viswanath

Vishalakshi Viswanath

Explore the profile of Vishalakshi Viswanath including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 72
Followers 0
Related Specialties
Dermatology
Infectious Diseases
Tropical Medicine
Top 10 Co-Authors
Resham Vasani
Pradnya Joshi
Tejas Vishwanath
Imran Majid
Dakshata Tare
Mayuri Dhakne
Raghunandan G Torsekar
Venkataram Mysore
Mrunal G Parab
Dhiraj Dhoot
Published In
Indian J Dermatol Venereol Leprol
Indian J Dermatol
Int J Dermatol
J Cutan Aesthet Surg
Dermatol Ther
Affiliations
Soon will be listed here.
Recent Articles
1.
A Potpourri of Trichoscopic Findings: Unique Presentation of Hyperthyroidism-Induced Hair Changes
Salve V, Viswanath V, Joshi P, Dhakne M
Int J Trichology . 2024 May; 15(4):160-162. PMID: 38765722
Hyperthyroidism is known to cause thin, brittle hair, and premature graying. Hair shaft abnormalities in hyperthyroidism have not been described in the literature. A visible and microscopic change in the...
2.
Linear nodulo-ulcerative lesions on the leg in an elderly male
Jethwa M, Viswanath V, Sakhadeo U, Kori S
Indian J Dermatol Venereol Leprol . 2024 Apr; 90(5):673-675. PMID: 38594985
No abstract available.
3.
Asymptomatic Papules on the Scrotum in a Middle-Aged Male
Vishwanath T, Viswanath V, Joshi R
Indian Dermatol Online J . 2024 Mar; 15(2):360-362. PMID: 38550845
No abstract available.
4.
Dermoscopy guided thermolysis-A modification to improve ease of procedure
Vishwanath T, Udare S, Rajput S, Viswanath V
J Cosmet Dermatol . 2022 Dec; 22(4):1422-1423. PMID: 36575887
No abstract available.
5.
Evaluation of the Efficacy and Safety of Apremilast in the Management of Lichen Planus
Viswanath V, Joshi P, Dhakne M, Dhoot D, Mahadkar N, Barkate H
Clin Cosmet Investig Dermatol . 2022 Dec; 15:2593-2600. PMID: 36483748
Introduction: Lichen planus is a chronic disease with often disappointing and less than optimal treatment options. Apremilast modulates inflammatory signalling pathways which play a central role in the pathogenesis of...
6.
Optimizing full face subcision by means of a three-way connector and local anesthetic-filled syringe
Vishwanath T, Viswanath V, Joshi P, Patil S, Dhakne M
J Cosmet Dermatol . 2022 May; 21(10):5293-5294. PMID: 35500135
No abstract available.
7.
An Open-Label, Randomized, Prospective, Comparative, Three-Arm Clinical Trial to Evaluate the Safety and Effectiveness of Apremilast with Three Different Titration Methods in Patients with Chronic Plaque Psoriasis in India
Viswanath V, Joshi P, Lawate P, Tare D, Dhoot D, Mahadkar N, et al.
Psoriasis (Auckl) . 2022 May; 12:53-61. PMID: 35496380
Purpose: To minimize adverse effects (AEs), apremilast is recommended to titrate at the initiation of therapy. But still, many patients experience AEs, resulting in discontinuation of therapy. As a result,...
8.
A Quality of Life Study in Patients with Leprosy Using DLQI and WHOQOL-BREF Questionnaires
Tare D, Viswanath V, Pai K, Samel D
Indian J Dermatol . 2022 Jan; 66(5):574. PMID: 35068530
Context: India accounts for 60% of the global leprosy burden. Deformities lead to a negative impact on the quality of life (QoL). There is a paucity of Indian studies evaluating...
9.
Linear papules, plaques, and ulcers in a boy
Viswanath V, Vishwanath T, Joshi P, Dabherao S, Tare D
Pediatr Dermatol . 2021 Nov; 38(5):e41-e42. PMID: 34750878
No abstract available.
10.
Successful use of intravenous and intralesional rituximab in paraneoplastic pemphigus with Castleman's disease
Viswanath V, Tare D, Patil P
Int J Dermatol . 2021 Mar; 60(9):e352-e354. PMID: 33720390
No abstract available.